Chordoma Symptoms: Early Detection and Genetic Testing in India
Key Facts at a Glance
Chordoma is a rare cancer arising from notochord remnants. Common symptoms include localized pain, neurological deficits, and palpable masses. Early detection improves treatment outcomes.
- Sample Required: Blood or saliva for hereditary cancer genetic testing (if indicated)
- Fasting Rules: None required
- Turnaround Time (TAT): 2–3 weeks for genetic panel results
- Base Cost: [Insert Current 2026 Price]
Understanding Chordoma
Chordoma is a rare, slow-growing malignant tumor that originates from embryonic notochord remnants. These remnants persist into adulthood and can transform into cancer, typically affecting the sacrococcygeal region (tailbone), the base of the skull, or along the spinal column. Although chordoma accounts for less than 1% of all primary bone tumors, its location and potential for local recurrence make early detection critical.
Anatomy and Tumor Sites
The spine is a complex structure of vertebrae, discs, and nerves. Chordoma develops from notochord remnants and can occur at three primary sites:
- Sacrococcyx (tailbone): The most common site, accounting for ~50% of cases.
- Base of the Skull (clivus): Affects cranial nerves and brainstem functions.
- Mobile Spine (cervical, thoracic, lumbar): Less common but can cause spinal instability and nerve compression.
Symptoms to Monitor
Symptoms vary by tumor location and often develop insidiously. Persistent symptoms lasting more than two weeks warrant medical evaluation.
| Tumor Location | Common Symptoms | Additional Signs |
|---|---|---|
| Sacrococcygeal | Lower back or buttock pain, palpable mass | Bowel or bladder dysfunction, sciatica |
| Cranial (Skull Base) | Headache, facial pain, double vision | Hearing loss, nasal obstruction, hormonal imbalances |
| Spinal (Mobile) | Back pain radiating to arms or legs | Numbness, tingling, weakness, gait disturbance |
If you experience any of these symptoms, especially in combination, consult a healthcare professional promptly. Early diagnosis allows for less invasive treatment and better outcomes.
The Role of Genetic Testing
While most chordomas are sporadic, rare familial cases have been linked to germline mutations in genes such as TBXT (brachyury). Genetic testing for hereditary cancer syndromes may be considered for individuals with a strong family history of chordoma or related tumors. DNA Labs India offers comprehensive hereditary cancer panels using Next-Generation Sequencing (NGS) to identify pathogenic variants that increase cancer risk.
Genetic counseling is recommended before and after testing to interpret results and guide surveillance strategies. Early identification of genetic predisposition can lead to proactive monitoring and early intervention.
Maintaining Spinal Health
Although specific preventive measures for chordoma are not established, general health practices support overall well-being:
- Regular exercise and a balanced diet to maintain a healthy weight.
- Consistent medical check-ups, especially if you have a personal or family history of cancer.
- Avoid unnecessary radiation exposure when possible.
Conclusion
Chordoma is a rare cancer, but awareness of its symptoms and risk factors can save lives. Early detection remains the cornerstone of effective treatment. If you notice persistent symptoms or have a family history of chordoma, consult a physician and consider genetic testing at DNA Labs India. Our ISO 9001 certified laboratory provides accurate and timely results to support your healthcare decisions.
Written by: Dr. Ananya Sharma, MBBS, MD (Internal Medicine)
Medically Reviewed by: Dr. Rajesh Kumar, MS (Orthopedics), Fellowship in Spine Surgery
Last Updated: February 2026